Friday, February 10, 2012

Skin Care Home>
News>
New Psoriasis Drug Shows Promise in Trial

Share this page
Facebook
Twitter
Stumble
Email

Save to My Home

This helped!

New Psoriasis Drug Shows Promise in Trial

(Reuters) UPDATED 2009-12-16

Drugmaker Celgene Corp. is reporting that its new drug to treat psoriasis has shown promise in a new mid-stage clinical trial. The oral drug, called apremilast, significantly reduced symptoms of the skin condition in the trial. If eventually approved, apremilast would compete with the injected drug Enbrel, which also targets tumor necrosis factor (TNF) in the body. Read full story >

See all Skin Care News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media